CD8A and cancer: Tumour cells often up‐regulate NK activating receptor ligands and lose NK inhibitory receptor ligands, including MHC‐I molecules,4 and so this type of cancer cells can be eliminated by NK cells, whereas endogenous CD8+ T cells do not recognize them.